April 2026
Create an account to continue using Similarweb
View website metrics, keywords, top marketing channels, market research tools, and more.
Create your free accountopenalex.org
Global Rank
#116,662
8,171Showing Similarweb estimated data.
Publicly validate your site’s metrics by connecting your GA4
Reflect your success
Verify your website's traffic and engagement metrics by connecting to Google Analytics
Bounce Rate
35.89%
Pages per Visit
6.67
Avg Visit Duration
00:03:37
- Company
- - -
- Industry
- - -
Top 10 openalex.org Competitors
The Top 10 Sites Like openalex.org in April 2026 are ranked by their affinity to openalex.org in terms of keyword traffic, audience targeting, and market overlap
Access 160+ million publication pages and connect with 25+ million researchers. Join for free and gain visibility by uploading your research.
Global Rank
#305
11Bounce Rate
33.99%
Pages per Visit
4.25
Avg Visit Duration
00:03:28
Similarity Score
100%google scholar provides a simple way to broadly search for scholarly literature. search across a wide variety of disciplines and sources: articles, theses, books, abstracts and court opinions.
- Company
- - -
- Industry
- - -
Global Rank
- -
Country Rank
- -
Category Rank
- -
Bounce Rate
29.08%
Pages per Visit
5.60
Avg Visit Duration
00:06:46
Similarity Score
98%sciencedirect is the world's leading source for scientific, technical, and medical research. explore journals, books and articles.
Global Rank
#357
65Bounce Rate
40.16%
Pages per Visit
4.67
Avg Visit Duration
00:05:51
Similarity Score
92%Crossref runs open infrastructure to link research objects, entities, and actions, creating a lasting and reusable scholarly record that underpins open science. Together with our 24,000 members in 166 countries, we drive metadata exchange and support 2 billion monthly API queries, facilitating global research communication, for the benefit of society.
- Company
- - -
- Industry
- - -
Global Rank
#44,734
1,273Bounce Rate
55.38%
Pages per Visit
2.61
Avg Visit Duration
00:01:30
Similarity Score
88%A system of non-tradable credits that flow between individuals like karma, hence proposed under that name, is a mechanism for repeated resource allocation that comes with attractive efficiency and fairness properties, in theory. In this study, we test karma in an online experiment in which human subjects repeatedly compete for a resource with time-varying and stochastic individual preferences or urgency to acquire the resource. We confirm that karma has significant and sustained welfare benefits even in a population with no prior training. We identify mechanism usage in contexts with sporadic high urgency, more so than with frequent moderate urgency, and implemented as a simple (binary) karma bidding scheme as particularly effective for welfare improvements: relatively larger aggregate efficiency gains are realized that are (almost) Pareto superior. These findings provide guidance for further testing and for future implementation plans of such mechanisms in the real world.
- Company
- - -
- Industry
- - -
Global Rank
#1,951
51Bounce Rate
38.99%
Pages per Visit
3.09
Avg Visit Duration
00:04:22
Similarity Score
86%Quick guide to get started with Semantic Scholar Academic Graph API.
- Company
- - -
- Industry
- - -
Global Rank
#6,855
261Bounce Rate
47.56%
Pages per Visit
2.66
Avg Visit Duration
00:01:44
Similarity Score
85%the world’s largest collection of open access research papers
- Company
- - -
- Industry
- - -
Global Rank
#40,844
1,007Bounce Rate
55.99%
Pages per Visit
2.51
Avg Visit Duration
00:01:39
Similarity Score
81%Abstract Background Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection and the resulting coronavirus disease 2019 (Covid-19) have afflicted tens of millions of people in a worldwide pandemic. Safe and effective vaccines are needed urgently. Methods In an ongoing multinational, placebo-controlled, observer-blinded, pivotal efficacy trial, we randomly assigned persons 16 years of age or older in a 1:1 ratio to receive two doses, 21 days apart, of either placebo or the BNT162b2 vaccine candidate (30 μg per dose). BNT162b2 is a lipid nanoparticle–formulated, nucleoside-modified RNA vaccine that encodes a prefusion stabilized, membrane-anchored SARS-CoV-2 full-length spike protein. The primary end points were efficacy of the vaccine against laboratory-confirmed Covid-19 and safety. Results A total of 43,548 participants underwent randomization, of whom 43,448 received injections: 21,720 with BNT162b2 and 21,728 with placebo. There were 8 cases of Covid-19 with onset at least 7 days after the second dose among participants assigned to receive BNT162b2 and 162 cases among those assigned to placebo; BNT162b2 was 95% effective in preventing Covid-19 (95% credible interval, 90.3 to 97.6). Similar vaccine efficacy (generally 90 to 100%) was observed across subgroups defined by age, sex, race, ethnicity, baseline body-mass index, and the presence of coexisting conditions. Among 10 cases of severe Covid-19 with onset after the first dose, 9 occurred in placebo recipients and 1 in a BNT162b2 recipient. The safety profile of BNT162b2 was characterized by short-term, mild-to-moderate pain at the injection site, fatigue, and headache. The incidence of serious adverse events was low and was similar in the vaccine and placebo groups. Conclusions A two-dose regimen of BNT162b2 conferred 95% protection against Covid-19 in persons 16 years of age or older. Safety over a median of 2 mont
- Company
- - -
- Industry
- - -
Global Rank
#124,456
6,351Bounce Rate
56.89%
Pages per Visit
1.74
Avg Visit Duration
00:00:41
Similarity Score
79%Learn more about our institutional models for librarians and the benefits for researchers.
- Company
- PLOS
Global Rank
#16,322
274Bounce Rate
58.79%
Pages per Visit
1.85
Avg Visit Duration
00:01:58
Similarity Score
76%A peer-reviewed, open access journal in soil health, sustainable development, soil science, ecosystem services & biogeochemical cycles.
- Company
- - -
- Industry
- - -
Bounce Rate
60.49%
Pages per Visit
2.20
Avg Visit Duration
00:01:28
Similarity Score
74%openalex.org's top 5 competitors in April 2026 are: researchgate.net, scholar.google.com, sciencedirect.com, crossref.org, and more.
According to Similarweb data of monthly visits, openalex.org’s top competitor in April 2026 is researchgate.net. openalex.org 2nd most similar site is scholar.google.com, and closing off the top 3 is sciencedirect.com.
crossref.org ranks as the 4th most similar website to openalex.org and arxiv.org ranks fifth in April 2026.
The other five competitors in the top 10 list are semanticscholar.org, core.ac.uk, scienceopen.com, plos.org, and doaj.org.